Cancer patients face higher mortality and complications from acute cholecystitis

Analysis of 8,673 patients revealed that those with active malignancies experienced significantly elevated 30-day mortality, with an odds ratio of 5.85. Furthermore, cancer patients had greater rates of infectious complications, including sepsis and pneumonia. The cancer cohort was also more likely to receive nonoperative management. These disparities in clinical outcomes and treatment processes underscore the need for tailored strategies in managing acute cholecystitis among cancer patients, particularly in relation to their ongoing cancer therapies.